Hangzhou Diagens Biotechnology – Charm

Chinese company to use AI-powered chromosome testing to boost profits and fast-track IVF

3 hours ago02 mins

Biotech firm Hangzhou Diagens Biotechnology is banking on artificial intelligence-powered chromosome testing to drive profit growth following its Hong Kong listing, as China’s falling fertility rate spurs demand for assisted reproduction. “In China, many young people do not want to marry or have children, and by the time they decide to start a family, they…

Tong Ren Tang healthcare unit pulls Hong Kong IPO scheduled for Monday

6 days ago02 mins

Beijing Tong Ren Tang Healthcare Investment, a provider of healthcare services based on traditional Chinese medicine, postponed its Hong Kong initial public offering (IPO) on Friday, citing “prevailing market conditions” and other factors. The company was one of six trading debuts slated for Monday, including an exchange-traded fund (ETF) and firms involved in AI and…